Ghent University Academic Bibliography

Journal Article
A1
open access

Response to : 'Correspondence on 'Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial' by Cai and Peng response

Anna Molto, Desiree van der Heijde, Filip Van den Bosch (UGent) and Maxime Dougados

(2023) ANNALS OF THE RHEUMATIC DISEASES. 82(7).

Journal Article
A1
open access

Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis : results at week 104 from a randomised placebo-controlled withdrawal study

Robert B. M. Landewe, Denis Poddubnyy, Proton Rahman, Filip Van den Bosch (UGent) , Rebecca Bolce, Soyi Liu Leage, Jeffrey R. Lisse, So Young Park and Lianne Gensler

(2023) ANNALS OF THE RHEUMATIC DISEASES. 82(2). p.212-216

Add to list

Journal Article
A1
open access

EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis

Alen Zabotti, Gabriele De Marco, Laure Gossec, Xenofon Baraliakos, Daniel Aletaha, Annamaria Iagnocco, Paolo Gisondi, Peter Balint, Heidi Bertheussen, Wolf-Henning Boehncke, et al.

(2023) ANNALS OF THE RHEUMATIC DISEASES. 82(9). p.1162-1170

Add to list

Journal Article
A1
open access

ASAS-EULAR recommendations for the management of axial spondyloarthritis : 2022 update

Sofia Ramiro, Elena Nikiphorou, Alexandre Sepriano, Augusta Ortolan, Casper Webers, Xenofon Baraliakos, Robert B. M. Landewe, Filip Van den Bosch (UGent) , Boryana Boteva, Ann Bremander, et al.

(2023) ANNALS OF THE RHEUMATIC DISEASES. 82(1). p.19-34

Add to list

Journal Article
A1
open access

ASAS consensus definition of early axial spondyloarthritis

Victoria Navarro-Compan, Diego Benavent, Dafne Capelusnik, Desiree van der Heijde, Robert B. M. Landewe, Denis Poddubnyy, Astrid van Tubergen, Xenofon Baraliakos, Filip Van den Bosch (UGent) , Floris A. van Gaalen, et al.

(2023) ANNALS OF THE RHEUMATIC DISEASES.

Add to list

Journal Article
A1
open access

Distinct immune modulatory roles of regulatory T cells in gut versus joint inflammation in TNF-driven spondyloarthritis

Koen Venken (UGent) , Matthias Jarlborg (UGent) , Tine Decruy (UGent) , Céline Mortier (UGent) , Carolien Vlieghe (UGent) , Elisabeth Gilis (UGent) , Ann-Sophie De Craemer (UGent) , Julie Coudenys (UGent) , Isabelle Cambré, Devan Fleury, et al.

(2023) ANNALS OF THE RHEUMATIC DISEASES. 82(8). p.1076-1090

Add to list

Anti-RuvBL1/2 autoantibodies in patients with systemic sclerosis or idiopathic inflammatory myopathy and a nuclear speckled pattern

Jean-Baptiste Vulsteke, Yves Piette (UGent) , Carolien Bonroy (UGent) , Patrick Verschueren, Daniel Blockmans, Steven Vanderschueren, Kristl G Claeys, Petra De Haes, Jan Leo Lenaerts, Wim A Wuyts, et al.

(2022) ANNALS OF THE RHEUMATIC DISEASES. 81(5). p.742-744

Add to list

Response to : ‘Finding the right one’ by Zanwar

Thomas Renson (UGent) , Filip Van den Bosch (UGent) and Dirk Elewaut (UGent)

(2022) ANNALS OF THE RHEUMATIC DISEASES. 81(5).

Add to list

Journal Article
A1
open access

Efficacy and safety of risankizumab for active psoriatic arthritis : 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial

Andrew Ostor, Filip Van den Bosch (UGent) , Kim Papp, Cecilia Asnal, Ricardo Blanco, Jacob Aelion, Gabriela Alperovich, Wenjing Lu, Zailong Wang, Ahmed M. Soliman, et al.

(2022) ANNALS OF THE RHEUMATIC DISEASES. 81(3). p.351-358

Add to list

MRI lesions of the spine in patients with axial spondyloarthritis : an update of lesion definitions and validation by the ASAS MRI working group

Xenofon Baraliakos, Mikkel Ostergaard, Robert G. W. Lambert, Iris Eshed, Pedro M. Machado, Susanne Juhl Pedersen, Ulrich Weber, Manouk de Hooge (UGent) , Joachim Sieper, Denis Poddubnyy, et al.

(2022) ANNALS OF THE RHEUMATIC DISEASES. 81(9). p.1243-1251

Academic Bibliography

Response to : 'Correspondence on 'Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial' by Cai and Peng response

Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis : results at week 104 from a randomised placebo-controlled withdrawal study

EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis

ASAS-EULAR recommendations for the management of axial spondyloarthritis : 2022 update

ASAS consensus definition of early axial spondyloarthritis

Distinct immune modulatory roles of regulatory T cells in gut versus joint inflammation in TNF-driven spondyloarthritis

Anti-RuvBL1/2 autoantibodies in patients with systemic sclerosis or idiopathic inflammatory myopathy and a nuclear speckled pattern

Response to : ‘Finding the right one’ by Zanwar

Efficacy and safety of risankizumab for active psoriatic arthritis : 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial

MRI lesions of the spine in patients with axial spondyloarthritis : an update of lesion definitions and validation by the ASAS MRI working group

Contents

Support

Contact